Virus | Protein | Mechanism |
---|---|---|
B19 | ? | Counteracts NK cell differentiation, activation, and cytotoxicity by decreasing the expression of TNF-α mRNA [86] |
BK | ? | Decreases KIR3DS1 activating receptor [87] |
HPV | E6 and E7 | |
? | Downregulates the activating receptors NKp30, NKp46, and NKG2D [92] | |
? | Weakens the cytotoxic capacity of NK cells [93] | |
HCMV | UL16 | Avoids being detected by NK cells by binding to ULBP1 and MICB [94] |
UL18 | binds to an MHC-I inhibitory receptor LIR-1 [95] | |
UL40 | upregulates the expression of the HLA-E [96] | |
UL141 | Downregulates the surface CD112 and CD155 [97, 98] Downregulates surface TRAIL death receptors [99] | |
UL142 | downregulates the cell surface amount of MICA by retention in the cis-Golgi apparatus [100] | |
UL148A | Downregulates the MICA by lysosomal degradation [101] | |
US18 and US20 | ||
US9 | Downregulates MICA*008 by proteasomal degradation [104] | |
US12 | Targets different NK cell ligands, adhesion molecules, and cytokine receptors [105] | |
pp65 | Weakens the cytotoxic capacity of NK cells by disrupting the CD3ζ signaling pathway [79] | |
gp34, gp95, gpRL13, and gp68 | Avoids ADCC by acting as CD16 (FcγIII receptor) analogs [105] | |
HSV and VZV | ? | Decreases MICA, ULBP1, ULBP2, and ULBP3 [105] |
gD | Avoids being detected by NK cells by decreasing CD112 [106] | |
gE-gI complex | Avoids ADCC by acting as CD16 (FcγIII receptor) analogs [105] | |
HHV-7 | U21 | Downregulates the surface levels of MICA and MICB [107] Reduces the ULBP1 protein by lysosomal degradation [107] |
KSHV | ORF54-encoded protein | downregulates an unknown ligand of NKp44 [108] |
vMIP-II (vCCL2) | acts as an antagonist for Fractalkine and RANTES chemokine receptors to inhibit NK cell migration [109] | |
K5 | Downregulates MICA and AICL cell surface levels by intracellular retention [110] | |
SARS-CoV-2 | Spike | Increases the surface expression of HLA [111] |
DENV | ? | Avoids being detected by NK cells by upregulating MHC-I [112] |
HCV | ? | downregulates the expression of NKG2D and NKp30 [113] |
RSV | ? | downregulates the expression of NKG2D and NKp44 [114] |
EBOV | VP24 and VP35 | |
Marburg virus | VP40 | Blocks the type I IFNs signaling [117] |
HIV | nef | Decreases the cell surface amount of MICA, ULBP1, and ULBP2 [77] Decreases the NK cell activity by intracellular retention of NKp44 ligands [118] |
nef and vpn | downregulates the expression of NTB-A and CD155 [119,120,121] | |
? | Impairs the expression and function of NKG2D [122] |